Endogenous opiates and behavior: 2014

RJ Bodnar - Peptides, 2016 - Elsevier
This paper is the thirty-seventh consecutive installment of the annual review of research
concerning the endogenous opioid system. It summarizes papers published during 2014 …

Update on pharmacotherapy for treatment of opioid use disorder

D Ayanga, D Shorter, TR Kosten - Expert opinion on …, 2016 - Taylor & Francis
ABSTRACT Introduction: Opioid Use Disorder (OUD) is a significant public health concern,
negatively impacting the medical, psychological, and social domains of an individual's life as …

The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder

VI Reus, LJ Fochtmann, O Bukstein… - American Journal of …, 2018 - Am Psychiatric Assoc
The goal of this guideline1 is to improve the quality of care and treatment outcomes for
patients with alcohol use disorder (AUD), as defined by DSM-5 (American Psychiatric …

Opioid treatment at release from jail using extended‐release naltrexone: a pilot proof‐of‐concept randomized effectiveness trial

JD Lee, R McDonald, E Grossman, J McNeely… - …, 2015 - Wiley Online Library
Abstract Background and Aims Relapse to addiction following incarceration is common. We
estimated the feasibility and effectiveness of extended‐release naltrexone (XR‐NTX) as …

Extended-release naltrexone improves viral suppression among incarcerated persons living with HIV with opioid use disorders transitioning to the community: results …

SA Springer, A Di Paola, MM Azar… - JAIDS Journal of …, 2018 - journals.lww.com
Objective: To determine whether extended-release naltrexone (XR-NTX) would improve or
maintain viral suppression (VS) among prisoners or jail detainees with HIV and opioid use …

Medications for treatment of opioid use disorder among persons living with HIV

L Fanucchi, SA Springer, PT Korthuis - Current HIV/AIDS Reports, 2019 - Springer
Abstract Purpose of Review Recent HIV outbreaks have occurred as a result of the current
US opioid epidemic. Providing medications for opioid use disorder (MOUD) with methadone …

Pharmacological interventions for drug‐using offenders

AE Perry, M Neilson… - Cochrane Database …, 2015 - cochranelibrary.com
Background The review represents one in a family of four reviews focusing on a range of
different interventions for drug‐using offenders. This specific review considers …

Medication treatment for alcohol use disorder in special populations

A Malhotra, K Drexler, M Hsu… - The American Journal on …, 2023 - Wiley Online Library
Abstract Background and Objectives Alcohol use disorder (AUD) is a significant public
health concern, with underutilized effective treatments, particularly in special populations …

Addressing unhealthy alcohol use among people living with HIV: recent advances and research directions

EJ Edelman, EC Williams… - Current opinion in …, 2018 - journals.lww.com
Addressing unhealthy alcohol use among people living with HI... : Current Opinion in Infectious
Diseases Addressing unhealthy alcohol use among people living with HIV: recent advances …

Extended-release naltrexone improves viral suppression among incarcerated persons living with HIV and alcohol use disorders transitioning to the community: results …

SA Springer, A Di Paola, R Barbour… - JAIDS Journal of …, 2018 - journals.lww.com
Objective: To determine whether extended-release naltrexone (XR-NTX) would improve or
maintain viral suppression (VS) among incarcerated individuals with HIV and alcohol use …